Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine
Work
Year: 2025
Type: article
Abstract: Development of specific therapies addressing the underlying diseases’ mechanisms constitutes the basis of precision medicine. Transthyretin cardiac amyloidosis (ATTR-CM) is an exemplar of precise the... more
Source: European Heart Journal
Institutions Hospital Universitario Puerta de Hierro Majadahonda, Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Columbia University Irving Medical Center, Universidad Francisco de Vitoria +1 more
Cites: 85
Cited by:
Related to: 10
FWCI:
Citation percentile (by year/subfield):
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $4,570